These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30007556)

  • 1. Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis.
    Nizamic T; Murad MH; Allen LA; McIlvennan CK; Wordingham SE; Matlock DD; Dunlay SM
    JACC Heart Fail; 2018 Sep; 6(9):757-767. PubMed ID: 30007556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTERMACS Profiles and Outcomes Among Non-Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction.
    Samman-Tahhan A; Hedley JS; McCue AA; Bjork JB; Georgiopoulou VV; Morris AA; Butler J; Kalogeropoulos AP
    JACC Heart Fail; 2018 Sep; 6(9):743-753. PubMed ID: 30098970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
    Grubb CS; Truby LK; Topkara VK; Bohnen MS; Yuzefpolskaya M; DeFilippis EM; Kleet A; Nakagawa S; Haythe JH; Axsom K; Colombo P; Takeda K; Uriel N; Sayer G; Garan H; Naka Y; Farr M
    Am Heart J; 2021 Sep; 239():11-18. PubMed ID: 33984317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients: A Systematic Review and Meta-Analysis.
    Hernandez GA; Blumer V; Arcay L; Monge J; Viles-Gonzalez JF; Lindenfeld J; Goldberger JJ; Chaparro S
    JACC Heart Fail; 2018 Sep; 6(9):734-742. PubMed ID: 30098968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative Inotrope Therapy: A Narrative Review.
    Chuzi S; Allen LA; Dunlay SM; Warraich HJ
    JAMA Cardiol; 2019 Aug; 4(8):815-822. PubMed ID: 31268467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
    Malotte K; Saguros A; Groninger H
    J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home Therapies in Advanced Heart Failure: Inotropes and Diuretics.
    Graffagnino JP; Avant LC; Calkins BC; Swetz KM
    Curr Heart Fail Rep; 2020 Oct; 17(5):314-323. PubMed ID: 32830304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
    Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA
    Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.
    Metra M; Eichhorn E; Abraham WT; Linseman J; Böhm M; Corbalan R; DeMets D; De Marco T; Elkayam U; Gerber M; Komajda M; Liu P; Mareev V; Perrone SV; Poole-Wilson P; Roecker E; Stewart J; Swedberg K; Tendera M; Wiens B; Bristow MR;
    Eur Heart J; 2009 Dec; 30(24):3015-26. PubMed ID: 19700774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure.
    Levine BS
    J Cardiovasc Nurs; 2000 Jul; 14(4):76-93. PubMed ID: 10902105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.
    Adabag S; Roukoz H; Anand IS; Moss AJ
    J Am Coll Cardiol; 2011 Aug; 58(9):935-41. PubMed ID: 21851882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
    Martens P; Vercammen J; Ceyssens W; Jacobs L; Luwel E; Van Aerde H; Potargent P; Renaers M; Dupont M; Mullens W
    ESC Heart Fail; 2018 Aug; 5(4):562-569. PubMed ID: 29341466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes for patients with nonischemic cardiomyopathy taking intravenous inotropes versus those weaned from or never taking inotropes at cardiac resynchronization therapy.
    Adelstein E; Bhattacharya S; Simon MA; Gorcsan J; Saba S
    Am J Cardiol; 2012 Sep; 110(6):857-61. PubMed ID: 22681865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.
    Hashim T; Sanam K; Revilla-Martinez M; Morgan CJ; Tallaj JA; Pamboukian SV; Loyaga-Rendon RY; George JF; Acharya D
    Circ Heart Fail; 2015 Sep; 8(5):880-6. PubMed ID: 26179184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.
    Allen LA; Fonarow GC; Grau-Sepulveda MV; Hernandez AF; Peterson PN; Partovian C; Li SX; Heidenreich PA; Bhatt DL; Peterson ED; Krumholz HM;
    Circ Heart Fail; 2014 Mar; 7(2):251-60. PubMed ID: 24488983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Inotropes on Patient-Reported Health Status in End-Stage Heart Failure: A Review of Published Clinical Trials.
    Clarke JD; Riello R; Allen LA; Psotka MA; Teerlink JR; Lindenfeld J; Desai NR; Ahmad T
    Circ Heart Fail; 2021 Feb; 14(2):e007759. PubMed ID: 33530705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.